Results for tag: "Idiopathic Short Stature Drug"

Idiopathic Short Stature (ISS) is a condition characterized by a height that is significantly below the average for a person's age and gender. Endocrine and Metabolic Disorders Drugs are used to treat this condition, as they can help to stimulate growth in children who are not growing at a normal rate. These drugs are typically prescribed to children who have not responded to other treatments, such as growth hormone therapy. Commonly prescribed drugs include somatropin, mecasermin, and anastrozole. The ISS Drug market is a specialized market, as the drugs used to treat this condition are not widely used. However, the market is growing, as more and more children are being diagnosed with ISS. Companies in this market include Novo Nordisk, Pfizer, Eli Lilly, and Merck. Show Less Read more